Palatin Technologies Inc (PTN)
1.95
+0.05
(+2.63%)
USD |
NYAM |
Jun 28, 16:00
1.92
-0.03
(-1.54%)
After-Hours: 20:00
Palatin Technologies SG&A Expense (TTM): 13.34M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 13.34M |
December 31, 2023 | 14.84M |
September 30, 2023 | 14.98M |
June 30, 2023 | 15.29M |
March 31, 2023 | 16.57M |
December 31, 2022 | 16.04M |
September 30, 2022 | 16.18M |
June 30, 2022 | 16.51M |
March 31, 2022 | 16.11M |
December 31, 2021 | 17.11M |
September 30, 2021 | 18.84M |
June 30, 2021 | 17.34M |
March 31, 2021 | 14.84M |
December 31, 2020 | 12.91M |
September 30, 2020 | 10.26M |
June 30, 2020 | 9.765M |
March 31, 2020 | 10.06M |
December 31, 2019 | 9.806M |
September 30, 2019 | 9.491M |
June 30, 2019 | 9.699M |
March 31, 2019 | 9.009M |
December 31, 2018 | 9.601M |
September 30, 2018 | 9.138M |
June 30, 2018 | 8.642M |
March 31, 2018 | 7.902M |
Date | Value |
---|---|
December 31, 2017 | 10.26M |
September 30, 2017 | 9.945M |
June 30, 2017 | 9.610M |
March 31, 2017 | 9.503M |
December 31, 2016 | 6.139M |
September 30, 2016 | 6.188M |
June 30, 2016 | 6.179M |
March 31, 2016 | 5.972M |
December 31, 2015 | 5.696M |
September 30, 2015 | 5.763M |
June 30, 2015 | 5.678M |
March 31, 2015 | 5.396M |
December 31, 2014 | 5.475M |
September 30, 2014 | 5.032M |
June 30, 2014 | 4.961M |
March 31, 2014 | 5.161M |
December 31, 2013 | 5.028M |
September 30, 2013 | 5.049M |
June 30, 2013 | 5.067M |
March 31, 2013 | 4.714M |
December 31, 2012 | 4.979M |
September 30, 2012 | 4.997M |
June 30, 2012 | 5.046M |
March 31, 2012 | 4.999M |
December 31, 2011 | 4.610M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
9.491M
Minimum
Sep 2019
18.84M
Maximum
Sep 2021
14.00M
Average
14.91M
Median
SG&A Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 19.11M |
Outset Medical Inc | 137.84M |
Ligand Pharmaceuticals Inc | 52.89M |
Lumos Pharma Inc | 20.35M |
Galectin Therapeutics Inc | 5.993M |